Campbell Newman Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$850K Buy
12,801
+553
+5% +$46.8K 0.06% 80
2026
Q1
$1.22M Buy
12,248
+209
+2% +$27.3K 0.1% 80
2025
Q4
$1.46M Sell
12,039
-459
-4% -$57.6K 0.11% 83
2025
Q3
$1.4M Buy
12,498
+55
+0.4% +$6.44K 0.1% 81
2025
Q2
$1.67M Buy
12,443
+824
+7% +$90.5K 0.13% 76
2025
Q1
$782K Buy
11,619
+166
+1% +$11.4K 0.07% 96
2024
Q4
$714K Sell
11,453
-246
-2% -$22.9K 0.06% 95
2024
Q3
$1.84M Sell
11,699
-192
-2% -$29.6K 0.14% 70
2024
Q2
$1.79M Buy
+11,891
New +$1.43M 0.14% 65

Other funds holding TMDX

Campbell Newman Asset Management's TMDX Position: Q2 2026 in Review

Campbell Newman Asset Management increased its Transmedics (TMDX) stake by 4.5% in Q2 2026, buying an estimated $46.8K and bringing the position to 12,801 shares worth $850K. The position accounts for 0.06% of the portfolio, ranked #80.

Campbell Newman Asset Management first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.84M in Q3 2024. 84 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Campbell Newman Asset Management held 12,801 shares of Transmedics worth $850K as of Q2 2026.
  • Campbell Newman Asset Management bought 553 Transmedics shares in Q2 2026, an estimated $46.8K.
  • Transmedics made up 0.06% of Campbell Newman Asset Management's portfolio in Q2 2026, its #80 holding.
  • Campbell Newman Asset Management first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
  • Campbell Newman Asset Management's Transmedics position peaked at $1.84M in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Campbell Newman Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.